blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1309322

EP1309322 - USE OF 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF RETINAL DISORDERS [Right-click to bookmark this link]
Former [2003/20]METHOD OF TREATING NEURODEGENERATIVE DISORDERS OF THE RETINA AND OPTIC NERVE HEAD
[2006/03]
StatusNo opposition filed within time limit
Status updated on  27.04.2007
Database last updated on 13.11.2024
Most recent event   Tooltip25.07.2008Change - representativepublished on 27.08.2008  [2008/35]
Applicant(s)For all designated states
Alcon, Inc.
Bösch 69
6331 Hünenberg / CH
[2006/02]
Former [2003/20]For all designated states
Alcon, Inc
Bosch 69, P.O. Box 62
6331 Hünenberg / CH
Inventor(s)01 / GAMACHE, Daniel, A.
5610 Hunterwood Lane
Arlington, TX 76017 / US
02 / GRAFF, Gustav
6500 County Road 809
Cleburne, TX 76031 / US
03 / YANNI, John, M.
2821 Donnybrook Drive
Burleson, TX 76028 / US
04 / KAPIN, Michael, A.
3602 Silkwood Trail
Arlington, TX 76016 / US
 [2003/20]
Representative(s)Hanna, Peter William Derek, et al
Hanna Moore + Curley
Garryard House
25/26 Earlsfort Terrace
Dublin 2, D02 PX51 / IE
[N/P]
Former [2008/35]Hanna, Peter William Derek, et al
Hanna Moore & Curley 13 Lower Lad Lane
Dublin 2 / IE
Former [2003/33]Hanna, Peter William Derek, et al
Hanna, Moore & Curley, 11 Mespil Road
Dublin 4 / IE
Former [2003/20]Hanna, Peter William Derek
Peter Hanna Associates 11 Mespil Road
Dublin 4 / IE
Application number, filing date01959734.313.08.2001
[2003/20]
WO2001US25319
Priority number, dateUS20000225132P14.08.2000         Original published format: US 225132 P
[2003/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0213805
Date:21.02.2002
Language:EN
[2002/08]
Type: A2 Application without search report 
No.:EP1309322
Date:14.05.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 21.02.2002 takes the place of the publication of the European patent application.
[2003/20]
Type: B1 Patent specification 
No.:EP1309322
Date:21.06.2006
Language:EN
[2006/25]
Search report(s)International search report - published on:EP30.05.2002
ClassificationIPC:A61K31/215, A61K31/165, A61K31/185, A61P25/02, A61P27/02
[2006/06]
CPC:
A61K31/24 (EP,US); A61K31/165 (EP,US); A61K31/195 (EP,US);
A61K31/196 (EP,US); A61P25/02 (EP); A61P27/02 (EP);
A61P9/00 (EP); A61P9/10 (EP) (-)
Former IPC [2003/20]A61K31/215, A61K31/165, A61K31/185, A61P9/00
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/20]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERWENDUNG VON 3-BEZOYLPHENYLESSIGSÄURE-DERIVATEN ZUR BEHANDLUNG VON NETZHAUTERKRANKUNGEN[2006/03]
English:USE OF 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR THE TREATMENT OF RETINAL DISORDERS[2006/03]
French:UTILISATION THERAPEUTIQUE DE DERIVES D'ACIDE 3-BENZOYLPHENYLACETIQUE POUR TRAITER LES AFFECTIONS DE LA RETINE[2006/03]
Former [2003/20]VERFAHREN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN DER RETINA ODER DER SEHNERVENENDUNG
Former [2003/20]METHOD OF TREATING NEURODEGENERATIVE DISORDERS OF THE RETINA AND OPTIC NERVE HEAD
Former [2003/20]PROCEDE POUR TRAITER DES TROUBLES NEURODEGENERATIFS DE LA RETINE ET DE LA PAPILLE OPTIQUE
Entry into regional phase07.02.2003National basic fee paid 
07.02.2003Designation fee(s) paid 
07.02.2003Examination fee paid 
Examination procedure04.03.2002Request for preliminary examination filed
International Preliminary Examining Authority: US
07.02.2003Amendment by applicant (claims and/or description)
07.02.2003Examination requested  [2003/20]
18.03.2004Despatch of a communication from the examining division (Time limit: M04)
09.07.2004Reply to a communication from the examining division
13.10.2005Despatch of a communication from the examining division (Time limit: M02)
23.11.2005Reply to a communication from the examining division
25.01.2006Communication of intention to grant the patent
02.05.2006Fee for grant paid
02.05.2006Fee for publishing/printing paid
Opposition(s)22.03.2007No opposition filed within time limit [2007/22]
Fees paidRenewal fee
25.08.2003Renewal fee patent year 03
23.08.2004Renewal fee patent year 04
19.08.2005Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2007/45]
Former [2007/36]IT21.06.2006
Cited inInternational search[DA]US4045576  (WELSTEAD JR WILLIAM J, et al);
 [DA]US4254146  (WALSH DAVID A);
 [DA]GB2071086  (ROBINS CO INC A H);
 [DA]US4313949  (SHANKLIN JR JAMES R, et al);
 [A]DE3026402  (SYNTEX CORP [US]);
 [DA]GB2093027  (ROBINS CO INC A H);
 [DA]US4503073  (WALSH DAVID A [US], et al);
 [DA]US4568695  (MORAN HENRY W [US], et al);
 [DA]US4683242  (POSER RICHARD G [US]);
 [DA]EP0326915  (SENJU PHARMA CO [JP], et al);
 [DA]US5475034  (YANNI JOHN M [US], et al);
 [A]US5811446  (THOMAS PETER G [US]);
 [DX]US6066671  (YANNI JOHN M [US], et al) [DX] 1-12 * claims 1,2 *;
 [PX]WO0128474  (ALCON UNIVERSAL LTD [CH], et al) [PX] 1-12 * page 1, line 1 - page 2, line 14; claims 1-35 *;
 [E]US6342524  (HELLBERG MARK R [US], et al) [E] 1-12 * claims 1-6 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.